Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Enorama Pharma AB
AB
Active
Org 5567165591
Strandvägen 7 A, 114 51
Stockholm
Manufacture of other food products n.e.c.
·
NACE 1089
Est. 2006 · 19 years old
5-9 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of other food products n.e.c.
/
Enorama Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
3M
6M
9M
13M
2M
2020
11M
2021
7M
2022
1M
2023
0M
2024
EBITDA
SEK millions
0M
-12M
-24M
-37M
-49M
-23M
2020
-23M
0%
2021
-27M
-17%
2022
-39M
-44%
2023
-13M
+67%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 146
10 844
6 726
1 358
0
Staff expenses
—
—
—
—
—
EBITDA
−22 689
−23 124
−27 128
−38 579
−13 047
Depreciation & amort.
−322
−1 381
−3 547
−3 548
−20 399
EBIT
−23 011
−24 505
−30 675
−42 127
−33 446
Net financials
−445
−764
−940
−2 486
3 573
Profit before tax
−23 456
−25 269
−30 800
−44 613
−27 308
Tax
−0
−0
−0
−0
−0
Net profit
−23 456
−25 269
−30 800
−44 613
−27 308
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
40 905
52 809
62 867
34 385
67 056
Equity
1 777
23 936
46 078
19 538
59 198
Long-term debt
20 516
17 901
4 771
4 629
0
Short-term debt
18 612
10 972
12 018
10 218
7 858
Total debt
39 128
28 873
16 789
14 847
7 858
Financial ratios
5-year trend
EBITDA margin
-1304700000.0%
This company
15.8%
Market median
-8257595037% vs market
2020
2024
Equity ratio
88.3%
This company
38.2%
Market median
+131% vs market
2020
2024
Return on equity
-46.1%
This company
18.4%
Market median
-351% vs market
2020
2024
Net profit margin
-2730800000.0%
This company
8.1%
Market median
-33713580347% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Enorama Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
